KORU Medical Systems Raises 2026 Revenue Guidance and Targets Year-End Cash Position
KORU Medical Systems (KRMD) has updated its financial outlook, raising its 2026 revenue guidance to a range of $48.0 million to $48.5 million. Despite experiencing a slowdown in top-line growth during the third quarter, management expressed confidence in a strong recovery for the final quarter of the year. CEO Adam Kalbermatten indicated that the company is on track to deliver high-teens growth in Q4. Additionally, the company has set a strategic target to maintain a cash position exceeding $8 million by the end of the year, signaling a focus on liquidity and operational stability.
